Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. (Q53580895)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 December 2006

Language	Label	Description	Also known as
English	Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.	scientific article published on 26 December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

0 references

0 references

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

author name string

Sakiko Ohga

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Kenichi Shikata

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Kosuke Yozai

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Shinichi Okada

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Daisuke Ogawa

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Hitomi Usui

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Yasushi Shikata

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Hirofumi Makino

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

publication date

26 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

292

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

F1141-50

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Aldose reductase and the role of the polyol pathway in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Transcription factor-kappa B (NF-kappa B) and renal disease.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Involvement of NF-kappaB in high glucose-induced alteration of alpha-methyl-D-glucopyranoside (alpha-MG) uptake in renal proximal tubule cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Identifiers

10.1152/AJPRENAL.00288.2005

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53580895&oldid=2221937066"